Real‐world evaluation of clinical outcomes in Dutch patients with type 2 diabetes treated with oral semaglutide: A retrospective, observational cohort study using the PHARMO data network

Documenti analoghi

• Real‐world retrospective study in elderly patients aged 65 years and older with type 2 diabetes mellitus treated with daily oral semaglutide ( SEMA ‐elderly)
  di: Vincenzo Fiore, et al.
  Pubblicazione: (2025)
• Effectiveness and safety of daily oral semaglutide in people with type 2 diabetes mellitus switching from sulfonylureas: A real‐world retrospective study
  di: Silvana Costa, et al.
  Pubblicazione: (2025)
• Diabetic kidney disease: The fourth pharmacological pillar may be semaglutide
  di: Dario Giugliano, et al.
  Pubblicazione: (2024)
• Real‐world glycated haemoglobin changes among type 2 diabetes mellitus patients treated with a maintenance dose of 7 mg or 14 mg of oral semaglutide
  di: Caroline Swift, et al.
  Pubblicazione: (2024)
• Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: A randomized controlled trial
  di: Maria Buur Nordskov Gabe, et al.
  Pubblicazione: (2024)